Symbol
| KLK5
| contributors: mct/pgu - updated : 10-07-2017
|
HGNC name
| kallikrein-related peptidase 5
|
HGNC id
| 6366
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in breast and ovarian cancer | tumoral
|  
|  
| --over
|  
|
in squamous cell carcinoma of the lung | tumoral
|  
|  
| --over
|  
|
in oral squamous cell carcinoma and may be implicated in malignant progression | tumoral
|  
|  
| --low
|  
|
in prostate and breast cancers | constitutional
|  
|  
| --other
|  
|
unregulated activities of KLK5 and KLK7 are responsible for Netherton syndrome (NS) development | |
Variant & Polymorphism
|
| |
Candidate gene
| potential biomarkers for breast cancer |
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
miscelleaneous | dermatology | | |
potential target for the treatment of skin disorders in which KLK activity is elevated |
| | |